| N |
|
NAD(P)H oxidase C242T gene variations and cardiovascular protection
|
| Soccio M., Pandolfi A., Di Castelnuovo A., Carluccio M., Ciccarone E., Toniato E., Martinotti S., Consoli A., Iacoviello L., Vanuzzo D., De Caterina R. |
| |
|
Natto Bacillus (Bacillus subtilis natto) as an oral fibrinolytic agent
|
| Sumi H., Yatagai C., Yanagisawa Y., Saito J. |
| |
|
Natural history of hepatitis C infection in hemophilia patients at Hospital Universitario Virgen del Rocío (Sevilla, Spain)
|
| Falantes J., Martínez M., Cisneros J. M., Pérez R. |
| |
|
Neonatal injection of human factor VIII induces immune tolerance in murine hemophilia A
|
| Madoiwa S., Yamauchi T., Hakamata Y., Kobayashi E., Arai M., Sugo T., Mimuro J., Sakata Y. |
| |
|
Neuroprotective functions of neuroserpin and PAI-1
|
| Lawrence D. |
| |
|
Neutral and charged lipids in factor Va inactivation
|
| Griffin J., Fernandez J. A., Gale A. J., Pecheniuk N., Yegneswaran S. |
| |
|
Neutrophil cathepsin G promotes prothrombinase and fibrin formation under flow by activating fibrinogen-adherent platelets
|
| Diamond S., Goel M. |
| |
|
Neutrophils rapidly recruited by TNF-a stimulated endothelial cells can exit the sub endothelial environment by reverse transmigration over hours: is this a novel route for neutrophil clearance from inflamed tissue?
|
| Stone P. C. W., Mcgettrick H. M., Nash G. B., Rainger G. E. |
| |
|
Neutrophils recruited by TNF-a stimulated endothelial cells down regulate subsequent endothelial VCAM-1 expression and inhibit the adhesion of a secondary bolus of flowing peripheral blood lymphocytes
|
| Stone P. C. W., Nash G. B., Rainger G. E. |
| |
|
New antiplatelet agents
|
| Clemetson K. |
| |
|
New automated von Willebrand factor activity assay to distinguish type 1 and type 2 von Willebrand disease (VWD)
|
| Piñol M., Costa M., Sales M., Federici A. B., Canciani M. T. |
| |
|
New chromogenic screening assay for detecting deficiencies in protein C and protein S
|
| Smirnov M., Safa O., Thomas E., Lawson D. |
| |
|
New data on the treatment of HIT (meta-analysis of three prospective studies of lepiruden in the prevention of thrombosis in patients with heparin-induced thrombocytopenia)
|
| Greinacher A. |
| |
|
New development in the diagnosis and management of thrombotic microangiopathy
|
| Tsai H. M. |
| |
|
New developments and indications for Arixtra
|
| Agnelli G. |
| |
|
New diagnostic guideline for coronary heart disease in old people
|
| Ma T., Jong G. P. |
| |
|
New functions of neutrophils in inflammation: tissue factor-triggered clotting induction and elastase-mediated fibrinolysis
|
| Imamura T., Nakamura S. |
| |
|
New insights into mechanisms of antiphospholipid syndrome
|
| Krilis S. |
| |
|
New insights into the pharmacology of Argatroban and potential clinical relevance
|
| Fareed J. |
| |
|
New mutations in the fibrinogen genes of patients with dys, hypo- or fibrinogenemia
|
| Czwalinna A., Wilhelm C., Hoffmann M., Lennemann K., Eisert R., Varvenne M., Ganser A., Von Depka M. |
| |
|
New oral anticoagulants
|
| Weitz J. |
| |
|
New parenteral anticoagulants
|
| Buller H. |
| |
|
New polymerization sites in the central and peripheral domains of human fibrin molecule
|
| Gritsenko P., Lugovskoy E. V., Kolesnikova I. M., Komisarenko S. V. |
| |
|
New risk factors for coronary artery disease: the endothelial nitric oxide synthase polymorphisms
|
| Sofi F., Gensini F., Fatini C., Sticchi E., Attanasio M., Lenti M., Margheri M., Giglioli C., Comeglio M., Abbate R., Gensini G. F. |
| |
|
Nine years experience at the AUB-MC vascular lab
|
| Ismail K., Aoun E., Sleiman Zade Asfahani W., Taher A. |
| |
|
Nitric oxide levels are up-regulated in patients with malignancy associated hypercoagulable state
|
| Fareed D., Bick R., Baker P., Ma Q., Hoppensteadt D. |
| |
|
Nitric oxide, cytokine and hemostasis in stroke
|
| Vitkovsky Y., Klimenko O. |
| |
|
Nitric oxide, endothelin-1 production and antithrombogenicity of endothelium in essential hypertension
|
| Savchenko S. |
| |
|
No episode of thrombocytopenia after four-week administration of fondaparinux, a new synthetic and selective inhibitor of factor Xa, in the PENTHIFRA-PLUS study
|
| Bauer K. A., Lassen M. R., Turpie A. G. G., Eriksson B. I. |
| |
|
No influence of alcohol intake on the pharmacokinetics or pharmacodynamics of the oral direct thrombin inhibitor, ximelagatran, in healthy volunteers
|
| Johansson S., Schützer K., Kessler M.-E., Sarich T., Eriksson U. G. |
| |
|
Non-catheter related pulmonary artery thrombosis in a premature
|
| Wiegand G., Rauch R., Girisch M., Hofbeck M. |
| |
|
Non-coagulant variants of thrombin are capable of activating procarboxypeptidase U
|
| Florian-Kujawski M., Hoppensteadt D., Ma Q., Jeske W., Fareed J. |
| |
|
Non-Hodgkin's lymphoma and antiphospholipid antibodies. Are they surrogate markers for relapse?
|
| Fraga M., Príncipe F., Mendes-Ribeiro M., Pereira R., Cunha-Ribeiro L. M. |
| |
|
Non-invasive detection of proximal DVT using bilateral compression ultrasound: methodology for the EXCLAIM study
|
| Schellong S., Hull R., Tapson V., Yusen R., Monreal M., Samama M. M., Turpie A. G. G., Cort S., Wildgoose P. |
| |
|
Non-lysine-analog plasminogen modulators: promotion of autocatalytic generation of plasmin(ogen) fragments with angiostatin-like activity and inhibition of tumor growth in vivo
|
| Hasumi K., Ohyama S., Hu W., Harada T., Abe S. |
| |
|
Nonmechanical intraoperative bleeding diathesis shows properties of a consumptive disorder allowing preoperative risk stratification
|
| Korte W., Wettstein P., Haeberli A., Stutz M., Rohner M., Gabi K., Schnider T. |
| |
|
Nonmethylated status of promoter CpG islands in human tissue factor gene
|
| Nakamura S., Okada M., Jung-Im H. |
| |
|
Normal arterial thrombus formation in integrin a2-deficient mice
|
| Gruener S., Schulte V., Holtkoetter O., Eckes B., Nieswandt B. |
| |
|
Normal platelet-poor plasma correction studies in the laboratory diagnosis of lupus anticoagulant
|
| Thom J. Y., Ivey L., Eikelboom J. |
| |
|
Normal pregnancy is associated with decreased protein Z levels in the second and third trimesters compared to early pregnancy
|
| Mpaidas M. J., Ku D. H., Arkel Y. S., Lee M. J., Rebarber A., Saha M., Davidson B., Lockwood C. J. |
| |
|
Normal values of total and free TFPI levels in the newborn and in children
|
| Van Dreden P., Woodhams B. J., Fontaine S., Deschamps A., Favier R. |
| |
|
Novel approaches to determine the characteristics of ADAMTS13 inhibitors in patients with acquired TTP
|
| Luken B. M., Turenhout E. A. M., Fijnheer R., Voorberg J. |
| |
|
Novel factor V mutations in three separate families resulting in factor V deficiency and bleeding
|
| Hong D. W., Schrijver I., Mandell L., Jones C. D., Dimichele D., Monahan P., Zehnder J. L. |
| |
|
Novel family based approaches to genetic risk in thrombosis
|
| Blangero J., Williams J. T., Almasy L. |
| |
|
Novel mutations in the factor X gene of a Taiwanese factor X-deficient patient
|
| Shen M., Lin J. S., Hsu S. C., Lin S. W., Lin B. |
| |
|
Novel polymorphic short tandem repeat in the human a2 integrin gene promoter is associated with GPIa/IIa density on the platelet surface
|
| Sydor W. J., Sanak M., Bazan-Socha S., Szczeklik A., Musial J. |
| |
|
Novel role for the membrane-bound chemokine fractalkine as a pathophysiologically relevant mechanism in platelet activation and adhesion
|
| Schäfer A., Schulz C., Eigenthaler M., Fraccarollo D., Gawaz M., Ertl G., Walter U., Bauersachs J. |
| |
|
Novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders
|
| Carmeliet P. |
| |
|
NovoSeven does not produce an inflammatory reponse in a monocyte (THP-1) cell line or primary monocytes prestimulated with lipopolysaccharide
|
| Hodgson A., Hochart H., Murphy C. V., Livingstone W., Smith O. P. |
| |
|
N-terminal disulfide knot of fibrin increases the accumulation of hyaluronic acid in the pericellular matrix of human umbilical vein endothelial cells
|
| Yevdokimova N., Lugovskoy E., Komisarenko S. |
| |
